SLC2A12
Solute carrier family 2, facilitated glucose transporter member 12
Also known as: GLUT12, GLUT8, GTR12_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TD20
- Gene
- SLC2A12
- Ensembl
- ENSG00000146411
- Chromosome
- 6
- Canonical length
- 617 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Cell Junctions
OverviewNCBI Gene
SLC2A12 belongs to a family of transporters that catalyze the uptake of sugars through facilitated diffusion (Rogers et al., 2002). This family of transporters show conservation of 12 transmembrane helices as well as functionally significant amino acid residues (Joost and Thorens, 2001 [PubMed 11780753]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
617 residues, UniProt reviewed canonical sequence.
>Q8TD20|SLC2A12
1 MVPVENTEGP SLLNQKGTAV ETEGSGSRHP PWARGCGMFT FLSSVTAAVS GLLVGYELGI
61 ISGALLQIKT LLALSCHEQE MVVSSLVIGA LLASLTGGVL IDRYGRRTAI ILSSCLLGLG
121 SLVLILSLSY TVLIVGRIAI GVSISLSSIA TCVYIAEIAP QHRRGLLVSL NELMIVIGIL
181 SAYISNYAFA NVFHGWKYMF GLVIPLGVLQ AIAMYFLPPS PRFLVMKGQE GAASKVLGRL
241 RALSDTTEEL TVIKSSLKDE YQYSFWDLFR SKDNMRTRIM IGLTLVFFVQ ITGQPNILFY
301 ASTVLKSVGF QSNEAASLAS TGVGVVKVIS TIPATLLVDH VGSKTFLCIG SSVMAASLVT
361 MGIVNLNIHM NFTHICRSHN SINQSLDESV IYGPGNLSTN NNTLRDHFKG ISSHSRSSLM
421 PLRNDVDKRG ETTSASLLNA GLSHTEYQIV TDPGDVPAFL KWLSLASLLV YVAAFSIGLG
481 PMPWLVLSEI FPGGIRGRAM ALTSSMNWGI NLLISLTFLT VTDLIGLPWV CFIYTIMSLA
541 SLLFVVMFIP ETKGCSLEQI SMELAKVNYV KNNICFMSHH QEELVPKQPQ KRKPQEQLLE
601 CNKLCGRGQS RQLSPETLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC2A12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 102 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 102 nTPM
- prostate: 21 nTPM
- stomach: 14 nTPM
- heart muscle: 10 nTPM
- small intestine: 9.2 nTPM
- seminal vesicle: 8.7 nTPM
Single-cell type
- choroid plexus epithelial cells: 993 nCPM
- retinal pigment epithelial cells: 601 nCPM
- prostatic glandular cells: 132 nCPM
- cardiomyocytes: 128 nCPM
- parietal cells: 106 nCPM
- respiratory ionocytes: 89 nCPM
Immune cell
- intermediate monocyte: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- choroid plexus: 185 nTPM
- cerebellum: 16 nTPM
- hippocampal formation: 12 nTPM
- basal ganglia: 9.8 nTPM
- cerebral cortex: 8.9 nTPM
- thalamus: 7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.31
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC2A12 as an antibody target. Whether an autoantibody or antibody against SLC2A12 could matter depends on whether native SLC2A12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC2A12 is annotated at the cell surface, where native SLC2A12 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC2A12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...